Treatment of heart failure

ES3079134T3Undetermined Publication Date: 2026-09-22CHILDRENS MEDICAL CENTER CORP (100 00)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
ES2020756733T
Authority / Receiving Office
ES · ES
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-02-15
Filing Date
2020-02-14
Publication Date
2026-09-22
Estimated Expiration
2040-02-14

Smart Images

  • Figure 00000028_0000
    Figure 00000028_0000
  • Figure 00000029_0000
    Figure 00000029_0000
  • Figure 00000030_0000
    Figure 00000030_0000
Patent Text Reader

Abstract

This disclosure relates to compositions comprising isolated mitochondria or combined mitochondrial agents, and to methods for treating disorders using such compositions. The methods described are based, at least in part, on the discovery that isolated mitochondria, either alone or bound to a therapeutic, diagnostic, or imaging agent, can be administered to patient tissue by injection into their blood vessels.
Need to check novelty before this filing date? Find Prior Art